These data as well as the time course profiles of the plasma glucose and insulin levels in an individual patient (S1 Fig) indicate that insulin resistance is highly prevalent in patients with ACS and further increased during acute phase of ACS attack. This evidence concerns the gene INS and Insulin resistance.